Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04171531 · ClinicalTrials.gov registry record · Phase 3
Sling vs Botox for Mixed Incontinence
A Phase 3 study, sponsored by NICHD Pelvic Floor Disorders Network.
- Completed
- Registry status
- Phase 3
- Development phase
- 150
- Enrollment target
NCT04171531 is a Phase 3 study that has completed, run by NICHD Pelvic Floor Disorders Network. The registered enrollment target is 150 participants.
The verdict
NCT04171531, a Phase 3 study, has completed, sponsored by NICHD Pelvic Floor Disorders Network.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 150 participants
- Enrollment target
Study Summary
The primary aim is to compare the effectiveness of intradetrusor injection of 100 unit injection of Botulinum toxin A to mid-urethral sling for change in MUI symptoms 6 months following treatment.
Interventions
- DRUG Botox® injection
- DEVICE Mid-urethral sling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2020-06-08 |
| Est. Completion | 2024-02-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04171531
The ClinicalTrials.gov registry entry for NCT04171531 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NICHD Pelvic Floor Disorders Network, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Botox® injection is the first listed.
NCT04171531 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04171531 about?
NCT04171531 is a clinical study titled "Sling vs Botox for Mixed Incontinence". The primary aim is to compare the effectiveness of intradetrusor injection of 100 unit injection of Botulinum toxin A to mid-urethral sling for change in MUI symptoms 6 months following treatment.
What is the current status of trial NCT04171531?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 150 participants. The study started on 2020-06-08. Estimated completion is 2024-02-12.
What interventions are being tested in trial NCT04171531?
The interventions under investigation include: Botox® injection (DRUG), Mid-urethral sling (DEVICE).
Who is sponsoring clinical trial NCT04171531?
This trial is sponsored by NICHD Pelvic Floor Disorders Network, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.